Sponsors

David Bennett moves to Viapath

  •  

Dr David Bennett, former head of NHS Foundation Trust regulator Monitor, has been appointed the new Chair of Viapath, the pathology joint venture owned by Guy’s and St Thomas’, King’s College Hospital and Serco.

Since its inception in 2009, Viapath has been a UK provider of pathology services to the NHS and private healthcare market. It employs 1300 scientists and other employees and provides one of the widest test repertoires in the NHS.

Other News

Leica Biosystems' new cryostat advances histology workflows

News

Feb 12, 2026
Link between influenza and heart disease revealed

News

Feb 10, 2026
Waters completes combination with BD's biosciences and diagnostic solutions businesses

News

Feb 10, 2026
Secure your place at the London Biotechnology Show

News

Feb 10, 2026
Vaccine ‘scaffolding’ boosts HIV immune response

News

Feb 10, 2026
Genetics technology developed to counter the rise of antibiotic resistance

News

Feb 09, 2026
AI solution for gastric cancer diagnostics

News

Feb 09, 2026
Immune 'hijacking' predicts cancer evolution

News

Feb 06, 2026
Newcastle Lynch syndrome test is rolled out across the UK for patients

News

Feb 05, 2026

Latest Issues

Epredia

Epredia was established in July 2019 through the acquisition by PHC Group of the Anatomical Pathology division of Thermo Fisher Scientific. Our name has changed, however as a standalone business our mission remains the same: to improve lives by enhancing cancer diagnostics.
We are powered by the quality brands you know and trust, such as...

Learn more »

BDIAP Molecular Pathology Study Day

10 Union Street, London, SE1 1SZ
2 March, 2026

Cell & Gene Therapy 2026

Hinxton Hall Conference Centre, Wellcome Genome Campus, Hinxton, CB10 1RQ
9-10 March, 2026

USCAP 115th Annual Meeting

Henry B. González Convention Center, San Antonio, Texas, USA
21 - 26 March, 2026